APA (7th ed.) Citation

Ammann, N., Schwietzer, Y. F., Meß, C., Stadler, J., Geidel, G., Kött, J., . . . Gebhardt, C. (2022). Activated eosinophils predict longer progression-free survival under immune checkpoint inhibition in melanoma. Cancers, 14(22), . https://doi.org/10.3390/cancers14225676

Chicago Style (17th ed.) Citation

Ammann, Nadine, et al. "Activated Eosinophils Predict Longer Progression-free Survival Under Immune Checkpoint Inhibition in Melanoma." Cancers 14, no. 22 (2022). https://doi.org/10.3390/cancers14225676.

MLA (9th ed.) Citation

Ammann, Nadine, et al. "Activated Eosinophils Predict Longer Progression-free Survival Under Immune Checkpoint Inhibition in Melanoma." Cancers, vol. 14, no. 22, 2022, https://doi.org/10.3390/cancers14225676.